Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a 300 mg I/mL solution for injection for intraarterial, intrathecal, and intravenous use. It enhances radiographic visualization of vascular and tissue structures during imaging procedures in patients requiring diagnostic angiography, CT scans, myelography, or cerebral angiography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iomeron, an iodinated contrast agent, improves X‑ray based imaging of vascular and tissue structures.

Angiography: provides enhanced visualization of blood vessels for diagnostic and interventional procedures. Computed tomography (CT) imaging: increases contrast between tissues, yielding clearer cross‑sectional images. Myelography: delineates the spinal canal and nerve roots with greater detail. Cerebral angiography: improves definition of cerebral vasculature for accurate assessment.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site - Nausea or vomiting - Mild headache - Metallic taste in the mouth - Transient urticaria or itching - Mild hypotension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute kidney injury, especially in patients with pre‑existing renal impairment - Seizures or neurological disturbances - Cardiac arrhythmias or severe hypotension - Pulmonary edema - Thyroid dysfunction due to iodine load

Before administering Iomeron, clinicians should evaluate patient risk factors and monitor for adverse events.

Renal function assessment: evaluate serum creatinine and eGFR, especially in patients with known kidney disease. Allergy history: screen for prior reactions to iodinated contrast or other allergens. Thyroid status: consider risk of iodine‑induced thyroid dysfunction in patients with hyperthyroidism. Pregnancy considerations: use only if clearly needed, as the agent is category B. Concurrent nephrotoxic drugs: avoid or adjust dosing when patients are receiving aminoglycosides, NSAIDs, or other renal‑impacting agents. Store below 25°C: keep in original packaging, protect from light and moisture.

Iomeron can interact with other substances that affect renal function or iodine load.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: cumulative iodine may increase toxicity. - Nephrotoxic medications (e.g., aminoglycosides, high‑dose NSAIDs): heightened risk of renal impairment. - Metformin in patients with reduced renal function: risk of lactic acidosis; consider temporary discontinuation.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: monitor thyroid function tests due to iodine load. - Diuretics: may exacerbate volume depletion and renal effects; adjust fluid management. - Anticoagulants during intrathecal administration: increased bleeding risk; monitor coagulation parameters.